- Home
- DERM vs LGCL Comparison
DERM vs LGCL Comparison
Compare DERM & LGCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- LGCL
- Stock Information
- Founded
- DERM 2014
- LGCL 2009
- Country
- DERM United States
- LGCL China
- Employees
- DERM N/A
- LGCL N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- LGCL
- Sector
- DERM Health Care
- LGCL
- Exchange
- DERM Nasdaq
- LGCL NYSE
- Market Cap
- DERM 124.4M
- LGCL 101.0M
- IPO Year
- DERM 2021
- LGCL 2024
- Fundamental
- Price
- DERM $5.12
- LGCL $1.17
- Analyst Decision
- DERM Strong Buy
- LGCL
- Analyst Count
- DERM 3
- LGCL 0
- Target Price
- DERM $9.50
- LGCL N/A
- AVG Volume (30 Days)
- DERM 159.2K
- LGCL 107.4K
- Earning Date
- DERM 11-12-2024
- LGCL 11-22-2024
- Dividend Yield
- DERM N/A
- LGCL N/A
- EPS Growth
- DERM N/A
- LGCL 11.49
- EPS
- DERM 0.04
- LGCL 0.14
- Revenue
- DERM $77,681,000.00
- LGCL $173,306,912.00
- Revenue This Year
- DERM N/A
- LGCL N/A
- Revenue Next Year
- DERM $37.38
- LGCL N/A
- P/E Ratio
- DERM N/A
- LGCL $8.41
- Revenue Growth
- DERM 26.38
- LGCL N/A
- 52 Week Low
- DERM $2.85
- LGCL $0.97
- 52 Week High
- DERM $8.11
- LGCL $5.00
- Technical
- Relative Strength Index (RSI)
- DERM 40.57
- LGCL N/A
- Support Level
- DERM $5.00
- LGCL N/A
- Resistance Level
- DERM $5.82
- LGCL N/A
- Average True Range (ATR)
- DERM 0.45
- LGCL 0.00
- MACD
- DERM -0.07
- LGCL 0.00
- Stochastic Oscillator
- DERM 8.99
- LGCL 0.00
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China.